Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
|
Results for 'Ono: Pipeline Products Performance Potential' |
|
|
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Ono Pharmaceutical: Pipeline, Products, Performance, Potential | Jan 2012 | £595 | 100% |
| World Pharmaceutical and Biopharmaceutical Market 2010-2015 (Pipeline Analysis of the Top 50 Companies) |
Jul 2010 | £2,845 | 76% |
| Evotec Aktiengesellschaft – Product Pipeline Review H2 2011 |
Nov 2011 | £315 | 76% |
| Osteoporosis & Bone Metabolism Disorders World Market 2010-2025 |
Apr 2010 | £1,499 | 74% |
| Commercial Insight: Osteoporosis Market players maximize revenue growth before the next challenging phase |
Jul 2010 | £9,615 | 70% |
| Osteoporosis Therapeutics Pipeline Assessment and Market Forecasts to 2018 |
Dec 2011 | £2,215 | 69% |
| DPP IV Inhibitors | Sep 2011 | £2,655 | 68% |
| World Multiple Myeloma Drug Treatment Market 2011-2021 |
Apr 2011 | £1,499 | 65% |
| Product Profiles: Osteoporosis Novel candidates offer the greatest potential |
Jun 2011 | £7,210 | 64% |
| Leading Anti-Cancer Drugs World Market Prospects 2011-2021 |
Feb 2011 | £1,499 | 58% |
| Multiple Sclerosis Treatment World Drug Market 2012-2022 |
Nov 2011 | £1,699 | 58% |
| Asthma and COPD Therapies World Market 2011-2021 |
Aug 2011 | £1,499 | 57% |
| World Diabetes Drug Market 2011-2021 |
Mar 2011 | £1,499 | 54% |
| Pipeline and Commercial Insight: Osteoporosis Novel agents to battle for payer acceptance |
Jul 2009 | £9,615 | 54% |
| Small-Molecule Targeted Cancer Therapies: World Market 2011-2021 |
Nov 2011 | £1,699 | 52% |
- Results 1 - 15 of 15
-
-
- 1
-
-
